Mayne Pharma Group Ltd
ASX:MYX

Watchlist Manager
Mayne Pharma Group Ltd Logo
Mayne Pharma Group Ltd
ASX:MYX
Watchlist
Price: 5.3 AUD 1.92% Market Closed
Market Cap: 450.9m AUD
Have any thoughts about
Mayne Pharma Group Ltd?
Write Note

Wall Street
Price Targets

MYX Price Targets Summary
Mayne Pharma Group Ltd

Wall Street analysts forecast MYX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MYX is 6.21 AUD with a low forecast of 5.99 AUD and a high forecast of 6.56 AUD.

Lowest
Price Target
5.99 AUD
13% Upside
Average
Price Target
6.21 AUD
17% Upside
Highest
Price Target
6.56 AUD
24% Upside
Mayne Pharma Group Ltd Competitors:
Price Targets
IOLCP
IOL Chemicals and Pharmaceuticals Ltd
27% Upside
000999
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
19% Upside
1477
Ocumension Therapeutics
86% Upside
214370
Caregen Co Ltd
24% Downside
NEULANDLAB
Neuland Laboratories Ltd
14% Downside
600380
Joincare Pharmaceutical Group Industry Co Ltd
16% Upside
NATCOPHARM
Natco Pharma Ltd
8% Downside
600572
Zhejiang CONBA Pharmaceutical Co Ltd
31% Upside

Revenue
Forecast

Revenue Estimate
Mayne Pharma Group Ltd

For the last 6 years the compound annual growth rate for Mayne Pharma Group Ltd's revenue is -5%. The projected CAGR for the next 3 years is 12%.

-5%
Past Growth
12%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Mayne Pharma Group Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Mayne Pharma Group Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MYX's stock price target?
Price Target
6.21 AUD

According to Wall Street analysts, the average 1-year price target for MYX is 6.21 AUD with a low forecast of 5.99 AUD and a high forecast of 6.56 AUD.

What is Mayne Pharma Group Ltd's Revenue forecast?
Projected CAGR
12%

For the last 6 years the compound annual growth rate for Mayne Pharma Group Ltd's revenue is -5%. The projected CAGR for the next 3 years is 12%.

Back to Top